Innovation Quarter is an innovation district that brings together multiple facets of life in the Winston-Salem and Piedmont Triad area. It is a mixed-use hub that encourages connection through proximity and fosters an innovation ecosystem for startups, growth companies, research, and education.

Innovation Quarter

Lightship Capital seeks entrepreneurs and funds who leverage modest resources to produce outsized returns, finding and developing remarkable talent while catalyzing emerging ecosystems. It claims that impact and profit are simultaneously achievable.

Lightship Capital

Amazon Web Services (AWS) provides cloud computing services, enabling businesses to build sophisticated applications with flexibility, scalability, and reliability.

Phoebe Wang

Amazon Web Services (AWS)

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Metric
Company Name	Innovation Quarter	Lightship Capital	Amazon Web Services (AWS)	Amgen Inc.
Symbol				AMGN
MSH ID	COM:INNOVATIONQUARTER	CAPITAL:LIGHTSHIP	COM:AMAZON:AWS	COM:AMGEN
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Commercial & Professional Services	Financial Services & Finance	Technology	Healthcare
Industry	Real Estate	Venture Capital	Cloud Computing	Drug Manufacturers - General
Country	US	US	US	US
Stage
Employee Count				26.70K
Website	innovationquarter.com	lightship.capital	aws.amazon.com	amgen.com
LinkedIn				amgen
Founders

Metric
Market Cap		172.56B
Enterprise Value
Monthly Web Traffic	12.37K	1.00M
Web Traffic Growth	0.15	-0.02
Valuation
Raised Capital		28.50B

Metric
Revenue				28.19B
Revenue (LTM)
Revenue (NTM)
Gross Profit				19.74B
EBITDA				7.90B
Operating Income				7.90B
Net Income				6.72B
EPS				12.56
Diluted EPS				12.49
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				0.70
Operating Profit Margin				0.32
EBITDA Margin				0.28
Net Profit Margin				0.24
Return on Equity				1.03
Return on Assets				0.07
Return on Capital Employed				0.12

INNO

COM:INNOVATIONQUARTER

Innovation Quarter

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				22.81
P/B Ratio				22.55
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				6.11
EV Multiple				12.57

Metric
Days Sales Outstanding				83.59
Days Payables Outstanding				69.95
Days Inventory Outstanding				411.08
Operating Cycle				513.92
Cash Conversion Cycle				445.24
Asset Turnover				0.34

Metric
Operating Cash Flow				8.47B
Free Cash Flow				7.36B
Cash Flow to Debt				0.13
Operating Cash Flow/Sales				0.30
Free Cash Flow Yield				0.06

Metric
Cash & Equivalents				10.94B
Accounts Receivable				-1.01B
Inventory				9.52B
Goodwill				18.63B
Debt to Capitalization				0.93
Debt to Assets				0.67
Current Ratio				2.86
Quick Ratio				1.62

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue				0.03
R&D to Revenue				0.17
SG&A to Revenue